Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells

Nature Protocols

Volumn 10, Issue 8, 2015, Pages 1143-1154

  Douvaras, Panagiotis ^a   Fossati, Valentina ^a  

^a New York Stem Cell Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GROWTH FACTOR; MEMBRANE ANTIGEN; MYELIN BASIC PROTEIN; O4 ANTIBODY; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; METHODOLOGY; MYELINATION; NEURAL STEM CELL; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL CULTURE; CELL SEPARATION; CYTOLOGY; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL SEPARATION; HUMANS; OLIGODENDROGLIA; PLURIPOTENT STEM CELLS;

EID: 84937873031     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2015.075     Document Type: Article

References (24)

1. Kassmann, C.M. et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 39, 969-976 (2007
2. Bartzokis, G. Brain myelination in prevalent neuropsychiatric developmental disorders: primary and comorbid addiction. Adolesc. Psychiatry 29, 55-96 (2005
3. Irion, S., Nostro, M.C., Kattman, S.J. &Keller, G.M. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications. Cold Spring Harb. Symp. Quant. Biol. 73, 101-110 (2008
4. Murry, C.E. &Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661-680 (2008
5. Wichterle, H., Lieberam, I., Porter, J.A. &Jessell, T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397 (2002
6. Nistor, G.I., Totoiu, M.O., Haque, N., Carpenter, M.K. &Keirstead, H.S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49, 385-396 (2005
7. Izrael, M. et al. Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol. Cell. Neurosci. 34, 310-323 (2007
8. Hu, B.Y., Du, Z.W., Li, X.J., Ayala, M. &Zhang, S.C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136, 1443-1452 (2009
9. Hu, B.Y., Du, Z.W. &Zhang, S.C. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat. Protoc. 4, 1614-1622 (2009
10. Numasawa-Kuroiwa, Y. et al. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes. Stem Cell Rep. 2, 648-661 (2014
11. Stacpoole, S.R. et al. High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology. Stem Cell Rep. 1, 437-450 (2013
12. Wang, S. et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12, 252-264 (2013
13. Liu, Y., Jiang, P. &Deng, W. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Nat. Protoc. 6, 640-655 (2011
14. Sim, F.J. et al. CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells. Nat. Biotechnol. 29, 934-941 (2011
15. Boulting, G.L. et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29, 279-286 (2011
16. Douvaras, P. et al. Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Rep. 3, 250-259 (2014
17. Kang, J. et al. Granulocyte colony-stimulating factor minimizes negative remodeling of decellularized small diameter vascular graft conduits but not medial degeneration. Ann. Vasc. Surg. 27, 487-496 (2013
18. Fennema-Notestine, C. et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63, 989-995 (2004
19. Behrendt, G. et al. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia 61, 273-286 (2013
20. Bernstein, H.G., Steiner, J., Guest, P.C., Dobrowolny, H. &Bogerts, B. Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr. Res. 161, 4-18 (2015
21. Chambers, S.M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275-280 (2009
22. Patani, R. et al. Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state. Nat. Commun. 2, 214 (2011
23. Miller, R.H. et al. Patterning of spinal cord oligodendrocyte development by dorsally derived BMP4. J. Neurosci. Res. 76, 9-19 (2004
24. Tomassy, G.S. &Fossati, V. How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses. Front. Cell. Neurosci. 8, 201 (2014